- Á propos
de l'ACMTS - Échange des
connaissances - Évaluation des
technologies
de la santé - Programme commun
d'évaluation
des médicaments - Service canadien de
prescription et d'utilisation
optimales des médicaments- Publications et outils
- Analogues de l’insuline
- Bandelettes de test glycémique
- Les thérapies optimales de deuxième intention pour traiter le diabète de type 2
- Base de données « prescription pour le changement »
- Les inhibiteurs de la pompe protons (IPP)
- Ressources en pharmacothérapie optimale
- Communiqué du SCPUOM
- Au sujet du SCPUOM
- Comités consultatifs
- Procédure du SCPUOM
- Contactez-nous
- Forum
politique
Publications et outils
-
RAPPORT SOMMAIRE : Prescription et utilisation optimales des bandelettes de test dans l’autosurveillance glycémique
le 8 décembre 2009
L’Agence canadienne des médicaments et des technologies de la santé (ACMTS) lance, par le truchement de son Service canadien de prescription et d’utilisation optimales des médicaments (SCPUOM), une série de rapports sur la thérapie optimale de l’a...
-
Gap Analysis and Key Messages for the Prescribing and Use of Blood Glucose Test Strips for the Self-Monitoring of Blood Glucose
le 12 novembre 2009
-
Projet du SCPUOM sur le diabète: optimiser l’autosurveillance glycémique: Énoncé de projet
le 12 novembre 2009
-
Optimal Therapy Recommendations for the Prescribing and Use of Blood Glucose Test Strips
le 28 juillet 2009
-
Second-Line Therapy for Patients with Diabetes Inadequately Controlled on Metformin — PROJECT PROTOCOL
le 28 juillet 2009
-
Cost-Effectiveness of Blood Glucose Test Strips in the Management of Adult Patients with Diabetes Mellitus
le 15 mai 2009
-
Systematic Review of Use of Blood Glucose Test Strips for the Management of Diabetes Mellitus
le 15 mai 2009
-
SUMMARY REPORT: Optimal Prescribing and Use of Insulin Analogues
le 31 mars 2009
-
Academic Detailing Upskilling Document – Insulin Analogues
le 31 mars 2009
-
Didactic Presentation for Pharmacists
le 31 mars 2009
-
Interactive Case Studies
le 31 mars 2009
-
Current Practice Analysis of Health Care Providers and Patients on Self- Monitoring of Blood Glucose
le 27 mars 2009
-
Current Utilization of Blood Glucose Test Strips in Canada
le 9 mars 2009
-
INSULIN MANAGEMENT: Evidence, Tips & Pearls1,2
le 9 mars 2009
-
le 20 janvier 2009
-
le 20 janvier 2009
-
Cadre d’évaluation
le 15 mai 2008
The Canadian Optimal Medication Prescribing and Utilization Service (COMPUS) is producing a collection of intervention tools to disseminate its key messages on proton pump inhibitors (PPIs). The following tools are being developed in collaboration with experts in continuing professional d...
-
Document « upskilling »
le 15 avril 2008
The academic detailing upskilling document on proton pump inhibitors is intended as a companion document to the Canadian Agency for Drugs and Technologies in Health’s (CADTH’s) Scientific Report entitled, Evidence for PPI Use in Gastroesophageal Reflux Disease, Dyspepsia and Peptic...
-
Analogues de l’insuline à action prolongée dans la prise en charge du diabète sucré : méta-analyses des résultats cliniques
le 25 mars 2008
Most studies of the long-acting insulin analogues were of poor quality and were not designed to measure differences in clinically important outcomes. There is no evidence that IGlar offers benefit over NPH insulin in children with type 1 DM, although IDet may have benefits in terms of reduce...
-
Évaluation économique des analogues de l’insuline dans la prise en charge des patients atteints du diabète des types I et II au Canada
le 25 mars 2008
The objective of this economic assessment was to determine the cost-effectiveness of using IAs in the management of T1DM and T2DM, compared to HIs, in Canada. The results of this analysis may assist those who are responsible for making informed judgments on the reimbursement and prescribing ...
-
Utilisation actuelle des produits d’insuline au Canada
le 1 mars 2008
To identify and promote the implementation of evidence-based and cost-effective optimal therapy in the prescribing and use of long and rapid-acting insulin analogues, COMPUS followed the process outlined in the flow chart to the right. This report represents Current Utilization Analysis step...
-
Analogues de l’insuline à action rapide dans la prise en charge du diabète sucré : méta-analyses des résultats cliniques
le 15 janvier 2008
The bulk of the available evidence on rapid-acting insulin analogues for both type 1 and type 2 diabetes consists of short- to medium-term comparisons with HI in terms of A1c and hypoglycemia. Most studies were of poor methodological quality. Based on the available evidence, the benefit of r...
-
Profils GRADE sur les analogues de l’insuline à action prolongée et rapide dans la prise en charge du diabète sucré
le 15 janvier 2008
The Canadian Optimal Medication Prescribing and Utilization Service (COMPUS) has applied the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach to its work. The GRADE approach was developed to assist recommendation-making groups in making judgments about the q...
-
Analyse des pratiques actuelles : analogues de l’insuline. Une analyse qualitative des perceptions et utilisations liées aux analogues de l’insuline
le 1 janvier 2008
For less than a decade, insulin analogues have been available to be used in combination with, or as replacements for, human insulins, providing new treatment options with type 1 or type 2 diabetes. Several recent reviews of randomized controlled trials comparing regular human and analogue in...
-
Outil d’auto-vérification à l’intention du médecin
le 1 septembre 2007
The Canadian Optimal Medication Prescribing and Utilization Service (COMPUS) self-audit tool is intended as a template and may be customized to suit the requirements of the distributor (provincial jurisdictions or continuing education providers, for example). The information collected enable...
-
Bulletin sur la formation continue en pharmacothérapie
le 15 avril 2007
Optimal Therapy Newsletter: Proton Pump Inhibitors...
-
Bloc d’ordonnances
le 15 avril 2007
-
Document « RxFiles Pearls »
le 15 avril 2007
OBJECTIVE COMPARATIVE DRUG INFORMATION & EDUCATION RxFiles Academic Detailing Program Saskatchewan’s Academic Detailing Program...
-
Présentation à l’intention des pharmaciens
le 1 avril 2007
Presentation for Pharmacists...
-
Aide à la prescription
le 1 avril 2007
-
Proton Pump Inhibitor Project Overview: Executive Summary
le 15 mars 2007
This Executive Summary is based on a comprehensive Scientific Report (Optimal Therapy Report – COMPUS: Evidence for PPI use in gastroesophageal reflux disease, dyspepsia and peptic ulcer disease: scientific report) and economic report on the topic, prepared by the Canadian Optimal Medi...
-
Current practice analysis report for the prescribing and use of proton pump inhibitors
le 15 mars 2007
The purpose of this report is to foster an understanding of how proton pump inhibitors (PPIs) are being prescribed and used in Canada. It is critical to have a clear picture of the current practice in Canada regarding PPIs so that gaps between the current practice and the optimal prescribing a...
-
Le projet en bref - The COMPUS PPI Project – From Evidence to Interventions to Improved Health Outcomes
le 15 mars 2007
Key Messages All PPIs are equally efficacious in the initial treatment of GERD, dyspepsia and other common GI conditions. Doubling the standard daily doses of PPIs, as initial therapy, is no better than standard daily dose therapy. PPIs are not efficacious in treating cough, asthma or laryngeal...
-
Analyse des lacunes sur la prescription et l’utilisation des inhibiteurs de la pompe à protons
le 1 mars 2007
The purpose of this report is to identify gaps in the current prescribing and use of PPIs. This document presents three gaps in the use of PPIs as determined by a review of current practice in the prescribing and use of PPIs in Canada compared with the Evidence Statements contained in theSci...
-
Rapport sur la sélection des interventions : projet IPP
le 1 mars 2007
The intent of this report is to identify a variety of interventions that would be best suited to optimizing the prescribing and use of proton pump inhibitors in different settings. While CADTH has taken care in the preparation of the report to ensure that its contents are accurate, complete an...
-
Proton Pump Inhibitor Project Overview: Summaries
le 1 mars 2007
-
Présentation didactique à l’intention des pharmaciens
le 1 février 2007
-
Présentation didactique à l’intention des médecins
le 1 février 2007
-
Présentation interactive à l’intention du médecin
le 1 février 2007
-
Données probantes sur l’utilisation des IPP dans le RGO, la dyspepsie et l’ulcère gastroduodénal : rapport scientifique
le 31 décembre 1969
1. ISSUE The Canadian Optimal Medication Prescribing and Utilization Service (COMPUS) was tasked by the federal, provincial, and territorial ministries of health to identify and promote the implementation of evidence-based and cost-effective optimal therapy in the prescribing and use of pro...
-
Economic models and conclusions for the treatment of dyspepsia; and gastroesophageal reflux disease – related heartburn and the prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal complications.
le 31 décembre 1969
The clinical and economic evidence for the treatment of common GI ailments (i.e., uninvestigatedm GERD, uninvestigated dyspepsia, and NSAID ulcer prophylaxis) in the general practice setting suggests that PPIs (at a price equal to or less than $1.25 per day) may be cost-effective depending on thewil...
-
Interventions for appropriate prescribing of proton pump inhibitors: a literature review
le 31 décembre 1969
The studies in the review suggest that combining educational multifaceted interventions that involve both professionals and patients with policy intervention may encourage appropriate prescribing and use of proton pump inhibitors. However, the decision on the selection of interventions shoul...
-
le 0 0000